Effect Of Virtual Reality Distraction on Symptom Control and Anxiety in Children With Leukemia (VR-Ege)
Symptom Cluster, Anxiety
About this trial
This is an interventional supportive care trial for Symptom Cluster
Eligibility Criteria
Inclusion Criteria: Pediatric patients aged 7-18 years receiving leukemia treatment in the Pediatric Hematology Service 4 weeks after diagnosis (not in the induction phase) No need for blood product transfusion (less than 8 mg/dl for hematological malignancies, less than 7 mg/dl for oncological malignancies) Consent to voluntarily participate in the study and written consent from the child and parent Exclusion Criteria: The child has a physical and psychological deficit that will prevent him from wearing glasses to watch virtual reality Having a symptom of nausea and vomiting Being in a terminal period Undergoing a surgical operation Unwillingness to participate in the study Having a history of vertigo (having a history of train, motion sickness) The child and family do not know Turkish
Sites / Locations
- Gülçin Özalp GerçekerRecruiting
- Figen YardımcıRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
virtual reality distraction
control
watching the application by wearing virtual glasses to the child during the 1st, 2nd and 3rd days of chemotherapy treatment
no virtual reality distraction